Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × deltacortene × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Burkitt Lymphoma 12 Prostatic Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Large B-Cell, Diffuse 4 Plasmablastic Lymphoma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Immunoblastic Lymphadenopathy 2 Enteropathy-Associated T-Cell Lymphoma 2 Neuroblastoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Hormone-Resistant Prostate Cancer 1 Hodgkin Disease 1 Hematologic Neoplasms 1 HIV Infections 1 Composite Lymphoma 1 Blast Crisis 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡